Interestingly, up-regulating GPR30 was also found in high-risk endometrial cancer patients with lower survival rates (9) and in tamoxifen-resistant breast cancer cells through the EGFR/ERK transduction pathway (49). This evidence concerns the gene EGFR and breast cancer.